Decheng Capital LLC
Top Portfolio Positions
16 positions ·
$721,751,003 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| CGON |
CG Oncology, Inc.
Healthcare
|
6,371,669 | $264,551,696 | 36.65% |
| NUVB |
Nuvation Bio Inc.
Healthcare
|
25,954,439 | $232,551,773 | 32.22% |
| UPB |
Upstream Bio, Inc.
Healthcare
|
3,143,078 | $85,334,567 | 11.82% |
| AARD |
Aardvark Therapeutics, Inc.
Healthcare
|
3,917,299 | $51,414,549 | 7.12% |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
592,057 | $20,769,359 | 2.88% |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
200,000 | $15,930,000 | 2.21% |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
541,559 | $12,905,350 | 1.79% |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
4,041,736 | $12,165,625 | 1.69% |
| EQ |
Equillium, Inc.
Healthcare
|
4,447,308 | $6,893,327 | 0.96% |
| BYSI |
BeyondSpring Inc.
Healthcare
|
3,800,702 | $6,195,144 | 0.86% |
Portfolio Trend
Holdings in PYXS
Export CSVShares Held
Position Value (USD)
9 of 9 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $375,831 | 326,810 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $725,518 | 326,810 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $359,491 | 326,810 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $320,273 | 326,810 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $509,823 | 326,810 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,199,392 | 326,810 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,081,741 | 326,810 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,392,210 | 326,810 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $588,258 | 326,810 | Shares | Sole | 2024-02-12 | |
| No quarters match your search. | ||||||